- EQS-News: Epigenomics AG: Executive Board member Jens Ravens leaves the Company on April 30, 2024
- EQS-NVR: Epigenomics AG: Release according to Article 41 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
- EQS-News: Epigenomics AG publishes financial results for fiscal year 2023
- EQS-AFR: Epigenomics AG: Preliminary announcement of the publication of financial reports according to Articles 114, 115, 117 of the WpHG [the German Securities Act]
Key statistics
On Thursday, Epigenomics AG (ECXX:GER) closed at 1.56, 0.65% above its 52-week low of 1.55, set on May 20, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 1.65 |
---|---|
High | 1.65 |
Low | 1.56 |
Bid | 1.65 |
Offer | 1.67 |
Previous close | 1.56 |
Average volume | 323.33 |
---|---|
Shares outstanding | 875.15k |
Free float | 584.34k |
P/E (TTM) | -- |
Market cap | 1.36m EUR |
EPS (TTM) | -19.49 EUR |
Data delayed at least 15 minutes, as of May 30 2024 15:24 BST.
More ▼